Corline Biomedical
11,2
SEK
+9,27 %
CLBIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
+9,27%
+13,82%
+27,56%
+57,75%
-6,67%
-22,76%
-11,11%
-22,96%
+13,23%
Corline Biomedical operates in the pharmaceutical industry. The company develops with the substance heparin and has developed a portfolio of drug candidates for use in connection with organ and cell transplantation. The drug candidates are based on the same basic technology as the medical technology products. Corline Biomedical operates on the Nordic market and is headquartered in Uppsala.
Læs mereMarkedsværdi
274,3 mio. SEK
Aktieomsætning
538,7 t SEK
Omsætning
25,03 mio.
EBIT %
-7,15 %
P/E
-
Udbytteafkast, %
-
Finanskalender
17.2
2025
Årsrapport '24
8.5
2025
Delårsrapport Q1'25
26.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Corline Biomedical AB: Will present at investor event hosted by Aktiespararna on June 3rd in Stockholm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools